In-Vitro Toxicology Testing Market Size and Forecast 2024-2033|Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc

Overview and Scope

In-vitro toxicology testing refers to assays and tests used to determine toxic doses of drugs, nutraceuticals, and food additives that cause toxicity when administered. It is used to detect the presence of toxic chemicals, and residual solvents and reduce hazardous exposure. This testing is mostly used to determine the doses of medications that exhibit toxicity in preclinical development, along with drug discovery and development.

Sizing and Forecast

The in-vitro toxicology testing market size has grown rapidly in recent years. It will grow from $10.31 billion in 2023 to $11.46 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to regulatory requirements, ethical concerns and animal welfare, cost and time efficiency, globalization of the pharmaceutical industry, drug discovery and development demands, public awareness of environmental toxins.

The in-vitro toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $17.13 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to focus on personalized medicine, demand for predictive toxicology models, expansion of environmental testing, oncology drug development challenges, focus on endocrine disruptor screening, shift towards multi-organ chips.. Major trends in the forecast period include advancements in 3d cell culture technologies, integration of high-throughput screening, focus on organ-on-a-chip technologies, application in chemical safety assessment, use of human-derived cell lines, incorporation of omics technologies, educational initiatives and training programs.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Segmentation & Regional Insights

The in-vitro toxicology testing market covered in this report is segmented –

1) By Product and Service: Consumables, Assays, Equipment, Software, Services

2) By Method: Cellular Assays, Biochemical Assays, In Silico Models, Ex Vivo Models

3) By Technology: Cell Culture Technologies, High-throughput Technologies, Toxicogenomics

4) By Applications: Neurotoxicity, Dermal toxicity, Cytotoxicity, Other Applications

5) By Industry: Pharmaceuticals and Biopharmaceuticals, Cosmetic and Household Products, Food, Chemicals

North America was the largest region in the in- vitro toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7987&type=smp

Major Driver Impacting Market Growth

Growing healthcare expenditure is expected to propel the in-vitro toxicology testing market going forward. Health expenditure is the amount of money spent by citizens and the government out of total income on hospitals, home health services, prescription pharmaceuticals, nursing facilities, and personal healthcare. Health expenditure is increasing in the world due to the rising prevalence of disease which utilizes in-vitro toxicology testing. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, it was estimated that between 2021 and 2030, national health spending is going to rise by an average of 5.1% every year, reaching almost $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending is going to rise at a 7.2% annual pace while Medicaid spending will rise at a 5.6% annual rate. Therefore, the growing healthcare expenditure is driving the in-vitro toxicology testing market.

Key Industry Players

Major companies operating in the in-vitro toxicology testing market report are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Abbott Laboratories, Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Quest Diagnostics Incorporated, Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation

The in-vitro toxicology testing market report table of contents includes:

1. Executive Summary

2. In-Vitro Toxicology Testing Market Characteristics

3. In-Vitro Toxicology Testing Market Trends And Strategies

4. In-Vitro Toxicology Testing Market – Macro Economic Scenario

5. Global In-Vitro Toxicology Testing Market Size and Growth

26. South America In-Vitro Toxicology Testing Market

27. Brazil In-Vitro Toxicology Testing Market

28. Middle East In-Vitro Toxicology Testing Market

29. Africa In-Vitro Toxicology Testing Market

30. In-Vitro Toxicology Testing Market Competitive Landscape And Company Profiles

Top Major Players: